Technological Advancements Revolutionizing Wound Closure and Advanced Wound Care
The primary intention of any wound closure and advanced wound care device is to ensure prompt and effective wound closure and rapid wound healing without the risk of any further wound-related complications. Highly prevalent acute and chronic wounds are in dire need of more efficient and robust therapeutic options that are driving the major global players and research institutes to develop efficacious, non-invasive and faster-wound repair mechanisms with minimal complications for their value-centric patients. Currently, the wound closure and advanced wound care device industry is undergoing a revolution due to the enormous number of innovations and development of technologically advanced products that are emerging in the market almost every other day. These technologically advanced products ensure functional closure of the wound non-invasively and in an aesthetically appealing manner, accelerated wound healing, reduction of the patient suffering, chances of wound complications and recurrence to improve the overall quality of life of patients by elevating independence and functional status of the patients. Compared to the traditional wound closure and wound care products, the current wound management products assure patients and healthcare providers with improved efficacy, effectiveness and faster healing of the wounds.
Wound closure and advanced wound care market is expected to reach $25,527.8 million by 2026 growing at a single digit CAGR from 2019 to 2026. Elevating inclination of the value-centric global patient pool towards the technologically advanced wound management products with better therapeutic outcomes and the need to reduce hospitalization duration and ease the patient’s condition through faster wound closure and accelerated wound healing time are boosting the various advancements in the wound closure and advanced wound care global market. To gain more market share by bringing innovative and differentiated products to the market and to stay abreast in the patient-driven market with smart and superior medical devices, the wound closure and wound care product manufacturing companies are constantly striving for the launch or approval of innovative wound management devices.
Advanced wound closure products like adhesives, sealants and haemostats are replacing the conventional, traumatizing wound closure devices like sutures, staples and ligating clips. Feasibility of these products for most of the surgical wounds, rapid termination of blood loss, prompt and effective wound closure, strong adhesion of wound edges, tight sealing, reduced scarring and reduced risk of infections are some the factors driving the market of these advanced wound closure products. Wound closure market is recently encountering an increasing inclination trend towards the wound closure strips that are easy to use, highly efficient, stronger and secure, with minimal scarring effects and also eliminates railroad marks associated with sutures and staples.
Some of the advanced wound care devices that have currently changed the face of wound care are negative pressure wound therapy (NPWT) system, hyperbaric oxygen therapy (HOT) systems and energy based devices. Minimal traumatizing effects on patients and better wound healing effects offered by the NPWT, minimal wound infection risks, reduced hospital stays, decreased wound dressing changes are some of the factors which are driving the market of NPWT. HOT market is mainly driven by its efficient and non-invasive nature of wound management, reduced risk of wound reopening, minimal scarring effects, technological up- gradations in the device that have led to the development of portable devices for use in home settings. Energy based devices like ultrasound devices, laser therapy systems, electrical stimulation devices, electromagnetic devices, ultraviolet devices and radiofrequency devices are currently being used for managing the most non-healing wounds and also some of the acute wounds. Accelerated wound healing, painless and scar less features of these techniques, minimal risk of infections and complications, increased tissue accessibility are some of the factors that are fuelling the market growth of these devices.
Advanced wound dressings incorporated with antimicrobial or wound healing agents and with up to 50% better and faster wound healing, low infection rate, painless removal of dressing, better cosmetic results with less scarring, non-requisite of frequent dressing changes leading to cost reduction, affordability and fewer drainage issues are substantially replacing the traditional wound dressings. The popularity of biologics in advanced wound management has increased substantially due to their efficient management of chronic wounds and burn injuries by restoring tissue integrity, elimination of frequent visits to physicians’ office for dressing changes, assurance of better therapeutic patient outcomes non-invasively and minimal scarring effects of these products. The biologics that are mainly used in wound management are growth factors and engineered skin substitutes.
Some of the major technological innovations in this field that are expected to be commercialized soon include nanoparticle-based wound healing and skin regeneration, smart wound dressings to monitor the progress of wound healing or to indicate the presence of infectious microbes in the wounds, gene therapy to alleviate wound healing by the introduction of normal healthy genes into the cells, stem cell technology to accelerate wound healing and skin remodeling, biochips for promoting the natural wound healing process and in the development of personalized wound management techniques and the micro anchor technology for the efficient, noninvasive wound closure.
Companies who are into conventional wound management products have to constantly incorporate value-based advanced technological features onto their products and upgrade their existing product portfolios to increase their market accessibility or to retain their market share. Global players like Medtronic and Ethicon are focusing on developing intelligence-based surgical staplers and staplers based on 3D Stapling Technology and Gripping Surface Technology (GST) for efficient closure and leak prevention from the wound. Companies are also developing automated suturing devices that are safer, quicker, easier and more accurate and accessible than conventional devices.
The wound closure and advanced wound care global market is fragmented with the top five players occupying only a minor market share and the major share of the market being occupied by other players. The top players in wound closure and advanced wound care market are Medtronic PLC (Ireland), 3M Company (U.S.), Smith & Nephew PLC (U.K.), Johnson & Johnson (J&J) (U.S.), Baxter International Inc. (U.S.), Molnlycke Holding AB (Sweden), Convatec Inc. (U.K.), Paul Hartmann AG (Germany), Integra LifeSciences Corporation (U.S.), Cardinal Health Inc. (U.S.), B. Braun Melsungen AG (Germany), Coloplast Group (Denmark) and others.
For more information please visit our website: https://www.iq4i.com/reports-category/medicaldevices/r/114
write to us: bd@iq4i.com
Phone: +91-8147030229